Active
Overview
- Legal name
- BIOLEGEND, INC.
- Registered location
- SAN DIEGO, CA, USA
- Website
- Company website ↗
- Primary NAICS
- 325414 — Biological Product (except Diagnostic) Manufacturing
- Latest award activity
- May 14, 2026
Read company summary
BIOLEGEND, INC. is associated with UEI WVJUG294HEM6 and CAGE 4PM02 in public federal records. AcornBids currently links 14 prime awards totaling $281.8K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Biological Product (except Diagnostic) Manufacturing; Analytical Laboratory Instrument Manufacturing; In-Vitro Diagnostic Substance Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 325414 (Biological Product (except Diagnostic) Manufacturing). Its public SAM.gov registration lists SAN DIEGO, CA, USA.
At a glance
Lifetime prime obligations$281.8K
Prime awards14
Awards with future end dates2
Top-agency concentration100.0%
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- BIOLEGEND, INC.
- UEI
- WVJUG294HEM6
- CAGE
- 4PM02
- Registered address
- 8999 BIOLEGEND WAY, SAN DIEGO, CA, 92121, USA
- Registration status
- Active
- Primary NAICS
- 325414 — Biological Product (except Diagnostic) Manufacturing
- SAM activation
- Jul 30, 2026
- Initial registration
- Mar 13, 2007
- Entity start
- Jul 21, 2021
- SAM updated
- Jul 30, 2026
- Registration expires
- Jul 28, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- CA, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N98026P00519MISSION BIO TAPESTRI SINGLE CELL DNA SEQUENCING BIOLEGEND INC:1135351 [26-004813] | Department of Health and Human Services | $22.8K | May 13, 2026 | Nov 12, 2026 |
| 75N98026P00452TOTALSEQ-D HUMAN HEME ONCOLOGY COCKTAIL BIOLEGEND INC:1135351 [26-004804] | Department of Health and Human Services | $16.5K | May 7, 2026 | Sep 30, 2026 |
| 75N93021P01445BIOLEGEND INC. AMBIS 2094398 | Department of Health and Human Services | $10.6K | Sep 17, 2021 | Oct 17, 2021 |
| 75N95D25P00107BIOLOGICAL AND REAGENT MATERIAL - BIOLEGEND FLOW CYTOMETER ANTIBODIES | Department of Health and Human Services | $14.0K | Sep 22, 2025 | Oct 21, 2025 |
| 75N92025P00372[25-014521]NIH NHLBI LABORATORY OF IMMUNE REGULATORY GENOMICS AND EPIGENOMICS REQUIRES TOTAL SEQ ANTIBODY COCKTAILS (MIXTURES OF ANTIBODIES CONJUGATED TO DNA OLIGONUCLEOTIDES FOR… | Department of Health and Human Services | $10.5K | Sep 11, 2025 | Nov 11, 2025 |
| 75N92025P00327BIOLEGEND TOTALSEQ-C REAGENTS | Department of Health and Human Services | $49.0K | Sep 10, 2025 | Oct 9, 2025 |
| 75N92025P00301[25-012698] THE LAB REQUIRES ANTIBODIES IN ORDER TO FOR IMMUNE CELL DISTRIBUTION AND FUNCTION IN SLEEP STUDY. | Department of Health and Human Services | $23.0K | Aug 6, 2025 | Nov 5, 2025 |
| 75N93025P00987BIOLEGEND, ANTIBODIES, SEE QUOTE- 1XAJL033125-NIAID | Department of Health and Human Services | $16.2K | May 14, 2025 | Jun 30, 2025 |
| 75N92025P00145[25-007798] LABS REQUIRE ANTIBODIES AND KITS FOR CELL ISOLATION IN ORDER TO FURTHER IDENTIFY CERTAIN CELLS THAT MAY AFFECT THE IMMUNE SYSTEM. | Department of Health and Human Services | $13.3K | Apr 2, 2025 | Jul 1, 2025 |
| 75N91025P00304ANTIBODIES FOR CLINICAL TRIAL PROTOCOL, WE WILL BE PERFORMING MULTI-PARAMETER FLOW-CYTOMETRIC ANALYSES FOR CIRCULATING IMMUNE SUBSETS ON OVER 230 CLINICAL SAMPLES, REQUIRING 30… | Department of Health and Human Services | $14.9K | Mar 31, 2025 | May 21, 2025 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Jul 30, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Mar 13, 2007 |
| Entity start | Jul 21, 2021 |
| Industry | Reported size status |
|---|---|
| 325414 — Biological Product (except Diagnostic) Manufacturing | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| BRIAN COLONNELLI | Government business | Contact method not published | SAM registration | Not available |
| BRIAN COLONNELLI | Alternate government business | Contact method not published | SAM registration | Not available |
| BRIAN COLONNELLI | Electronic business | Contact method not published | SAM registration | Not available |
| BRIAN COLONNELLI | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325414 — Biological Product (except Diagnostic) Manufacturing
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
276 awards
73 awards
65 awards
57 awards
49 awards
46 awards
36 awards
24 awards
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit